Repligen Corp (NASDAQ: RGEN) reported Q3 EPS of ($0.07), versus $0.01 reported last year. Revenue for the quarter came in at $7.17 million, versus $7.07 million reported last year.

For earnings history and earnings-related data on Repligen Corp (RGEN) click here.

Earnings